The following documents - version 1 - are showing the main differences between EUCAST and CLSI. They are based on the EUCAST breakpoint tables for interpretation of MCIs and zone diameters (version 1.1., april 2010) and the CLSI performance standards of antimicrobial susceptibility testing (M100-S20, 2010). The Swiss Antibiogram Committee will create an updated version (version 2) by the end of january 2011, because the new EUCAST version 1.2 has just been published (2010-12-22; cf. www.eucast.org).

download Liste EUCAST-CLSI Swiss Antibiogram Committee Version April 2012.pdf (german)

download Liste EUCAST-CLSI Swiss Antibiogram Committee Version April 2012.pdf (french)

download Liste EUCAST-CLSI Swiss Antibiogram Committee Version April 2012.pdf (italian)

Presentations of a joint meeting of the "Club de pathologie infectieuse" (Swiss Society of Infectious Diseases) and the "Réunion informelle SGM/SSM" organized by the SGM/SSM working group " Quality control - Swiss Antibiogram Committee" of January 26th, 2011 at the Langhans Auditorium in Bern.

(download) J. Bille: What is EUCAST, the tasks, the tools, the methods, the Swiss agenda and more

(download) R. Zbinden: EUCAST in the laboratory: major changes, reporting, and the organization in Switzerland

(download) J. Bille: Staphylococci and glycopeptides

(download) R. Frei: Enterobacteriaceae, nonfermenters and ß-lactams

(download) K. Mühlemann: CLSI and EUCAST recommend to no longer test for ESBL phenotype : should we stop to isolate ESBL carriers or reconsider specific hygiene measures for ESBL? Replace “ESBL”by “MDR-GN”?

(download) G. Zanetti: There is a need for alternatives to carbapenems against ESBL-producing enterobacteriaceae

(download) J. Bille: Enterococci and glycopeptides ... (not presented)